GCTK vs STE · P/E 0.1, $4.1M cap vs P/E 25, rev $5.94B
GlucoTrack Inc (GCTK) versus STERIS plc (STE) — a side-by-side from cached financials, not a winner call.
GlucoTrack Inc (GCTK) is a medical instruments & supplies company listed on US.
STERIS plc (STE) is a medical devices company listed on NYSE.
GCTK does not have a complete income-statement cache yet.
Latest reported STE revenue for 2026-03-31 was $5.94B. Net income was $782.3M. Revenue was up 8.7% from 2025-03-31 to 2026-03-31. STE currently screens at market cap $19.43B and trailing P/E 25.1.
GCTK currently screens at market cap $4.1M and trailing P/E 0.1. STE currently screens at market cap $19.43B and trailing P/E 25.1.
Not investment advice. Open the GCTK and STE stock pages for the full models.
Not investment advice.